Infections in the brain can have serious consequences and are often fatal. The immune defense system works differently here ...

The discovery may explain why cutting edge CAR T-cell therapy has managed to revolutionized treatment for blood cancer but ...

Cero will use Invivoscribe's multiparametric flow cytometry assay to detect minimal residual disease in patients and evaluate the therapy's efficacy.

New findings show that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...

Michael Green, PhD, discusses a new method of assessing lymphoma subtypes utilizing the tumor microenvironment.

Acute Myeloid leukaemia AML is a fast-growing cancer of the bone marrow that disrupts blood cell production It differs from ...

Scientists at St. Jude Children’s Research Hospital and University Health Network showed that the stage of B-cell development ...

A research team has discovered a previously unknown mechanism that could explain why many patients with aggressive B-cell lymphoma do not respond to CAR-T cell therapy in the long term. The results of ...

This webinar will discuss humanization of the NOG-EXL and hIL-6 NOG host strains, which both support a range of human cell types including myeloid and lymphoid lineages, along with considerations for ...

Proper blood composition and function requires that myeloid and lymphoid precursor cells differentiate into the blood cells that perform these life-sustaining tasks. Sometimes, these precursor cells ...

Bone marrow transplants, long a mainstay of blood cancer treatment, are becoming less common as more turn to alternatives like CAR-T therapy.

Researchers at University of California San Diego School of Medicine and their colleagues have developed the first comprehensive map of the dramatic changes that take place in the blood system over ...